Closing Bell: Briacell Therapeutics Corp down on Tuesday (BCT)

In market activity today, Briacell Therapeutics Corp shares closed at $0.85 after opening the day at $0.85. It traded at a low of $0.85 to a high of $0.86.

Shares dipped -9.57 percent from the previous day's close of $0.94.

During the day across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -3.00% at 5186.33, the Dow Jones Industrial Average closed -2.60% at 38703.27 and the Nasdaq Composite closed -3.43% at 16200.08.

Briacell Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker BCT.

Trading volume was 2,700 on 5 total trades, with an average volume of 2,956 over the last 5 days.

The TSX overall saw 3,772 price advancers against 1,443 declines and 86 unchanged.

During the prior 52 weeks, BCT.TO has traded as high as $10.29 (August 28,2023) and low as $0.84 (July 24,2024). Moreover, in the last 12 months, Briacell Therapeutics Corp's shares have plummeted -90.43 percent, while this year, they have shrunken -89.10%.

Following today's trading, Briacell Therapeutics Corp has a market capitalization of $17.19 million on a float of 18,285 shares outstanding. Its annual EPS is $-0.37.

Briacell Therapeutics Corp is a None company headquartered in Vancouver, CAN.

Currently, Briacell Therapeutics Corp has an average recommendation of "Strong Buy" based on 1.00 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..